DRG Range Myeloproliferative Diseases & Disorders, Poorly Differentiated Neoplasms

• 1  ACUTE LEUKEMIA WITH MCC     ( 834 )

• 2  ACUTE LEUKEMIA WITH CC     ( 835 )

• 3  ACUTE LEUKEMIA WITHOUT CC/MCC     ( 836 )

• 4  CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MCC     ( 837 )

• 5  CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC OR HIGH DOSE CHEMOTHERAPY AGENT     ( 838 )

• 6  CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC     ( 839 )

• 7  LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MCC     ( 840 )

• 8  LYMPHOMA AND NON-ACUTE LEUKEMIA WITH CC     ( 841 )

• 9  LYMPHOMA AND NON-ACUTE LEUKEMIA WITHOUT CC/MCC     ( 842 )

• 10  OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH MCC     ( 843 )

• 11  OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITH CC     ( 844 )

• 12  OTHER MYELOPROLIFERATIVE DISORDERS OR POORLY DIFFERENTIATED NEOPLASTIC DIAGNOSES WITHOUT CC/MCC     ( 845 )

• 13  CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MCC     ( 846 )

• 14  CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH CC     ( 847 )

• 15  CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITHOUT CC/MCC     ( 848 )

• 16  RADIOTHERAPY     ( 849 )

• 17  ACUTE LEUKEMIA WITH OTHER PROCEDURES     ( 850 )